Cargando…

History of lower-limb complications and risk of cancer death in people with type 2 diabetes

BACKGROUND: Individuals with diabetes and lower-limb complications are at high risk for cardiovascular and all-cause mortality, but uncertainties remain in terms of cancer-related death in this population. We investigated this relationship in a large cohort of people with type 2 diabetes. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammedi, Kamel, Harrap, Stephen, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Chalmers, John, Woodward, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784290/ https://www.ncbi.nlm.nih.gov/pubmed/33397352 http://dx.doi.org/10.1186/s12933-020-01198-y

Ejemplares similares

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
por: van der Leeuw, Joep, et al.
Publicado: (2016)

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
por: Blomster, Juuso I, et al.
Publicado: (2016)

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
por: Camoin, Marion, et al.
Publicado: (2022)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
por: Hua, X., et al.
Publicado: (2020)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022)

Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2015)

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus
por: Potier, Louis, et al.
Publicado: (2018)

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
por: Oshima, Megumi, et al.
Publicado: (2019)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
por: Lin, Chu, et al.
Publicado: (2021)

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hillis, Graham S., et al.
Publicado: (2012)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
por: van Steen, Sigrid C., et al.
Publicado: (2018)

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
por: Nativel, Mathilde, et al.
Publicado: (2018)

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
por: Tremblay, Johanne, et al.
Publicado: (2021)

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
por: Harris, Katie, et al.
Publicado: (2020)

Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes
por: Schneider, Fabrice, et al.
Publicado: (2018)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
por: Thomas, Merlin C., et al.
Publicado: (2018)

Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis
por: Clarke, Philip M., et al.
Publicado: (2010)

Unraveling the history of limb bones
por: Woodward, Holly N
Publicado: (2021)

Digital Variance Angiography in Lower-Limb Angiography with Metal Implants
por: Bastian, M. B., et al.
Publicado: (2020)

Association of Maternal History of Neonatal Death With Subsequent Neonatal Death in India
por: Kapoor, Mudit, et al.
Publicado: (2020)

Cardiac Complications of Diabetes
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
por: Sanchez, Manuel, et al.
Publicado: (2022)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
por: Li, Kevin, et al.
Publicado: (2020)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

Cycling in people with a lower limb amputation
por: Poonsiri, Jutamanee, et al.
Publicado: (2021)

Influence of changing trends in anaesthetic practice on morbidity and mortality in elderly patients undergoing lower limb surgery
por: Srilata, Moningi, et al.
Publicado: (2014)

Limb lengthening history, evolution, complications and current concepts
por: Hosny, Gamal A.
Publicado: (2020)

Social relations and exclusion among people facing death
por: Seppänen, Marjaana, et al.
Publicado: (2023)

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009)

The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization
por: Kadoglou, Nikolaos P. E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jrp6q5rmkgahbbh6e910vs0r9a